ArticleInfectious diseases of poverty2026
Readmission and survival of hospitalized pulmonary tuberculosis patients: a nationwide record-based cohort analysis in Thailand (2017-2022).
Article in Infectious diseases of poverty, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundAssessing the readmitted diseases and survivors in patients hospitalized with pulmonary tuberculosis (TB) is crucial for healthcare strategies tailored to TB survivors. This study aims to compare readmissions and survival of hospitalized pulmonary TB patients with those of their matched controls in Thailand.
methodsWe retrieved inpatient drug-sensitive pulmonary TB cases from the Thai Health Information Portal database (2017-2022), which included all hospitalized admissions in Thai hospitals. Non-TB controls were selected using 1∶1 propensity score matching by admission date, location, sex, age, and comorbidities. Time to readmission and to death event were the outcome variables. Cox regression with a robust variance sandwich estimator was used and then the E-value was computed. E-values indicate the strength of possible unexplained confounders.
resultsFrom the propensity score matching, a total of 59,027 patients newly admitted for TB could be matched with 59,027 non-TB inpatient controls. Hazard ratios (HR) with 95% confidence intervals (CI) and E-values for causes of readmission among TB patients were 5.4 (2.1-14.3) and 10.2 for pericarditis, 5.4 (4.1-7.2) and 10.2 for pneumothorax, 3.8 (2.9-4.9) and 7.1 for bronchiectasis, 3.1 (2.4-4.2) and 5.6 for hyperfunction of the pituitary gland, and 2.4 (2.1-2.8) and 4.2 for inflammatory liver diseases. The TB cohort also had a higher risk of death [HR = 1.5 (95% CI: 1.4-1.6) and E-value = 2.3].
conclusionsHospitalized TB patients in Thailand are at higher risk than their non-TB controls in getting readmissions for thoracic problems and death. These problems call for improvement of TB care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.